The primary GBM cells (GBM3 and GBM4) were characterized for the mutational status of IDH1/IDH2, methylation of MGMT and p53, and EGFR amplification (Table 1) as described in the Materials and Methods. The gene discussed is EGFR; the disease is glioblastoma.